Senate investigation: drugmaker harmed patients, profited, with asthma inhaler switch
Senate investigation: drugmaker harmed sufferers, profited, with asthma inhaler switch In 2024, medical doctors and fogeys scrambled to search out an inexpensive asthma inhaler after drugmaker GSK pulled the favored…